Evidence map›Paper›PMID 36316783›Full record

ArticleMolecular neurodegeneration2022

Common features of neurodegenerative disease: exploring the brain-eye connection and beyond (part 2): the 2021 pre-symposium of the 15th international conference on Alzheimer's and Parkinson's diseases.

Sharyn L Rossi, Preeti Subramanian, Guojun Bu, Adriana Di Polo, Todd E Golde, Diane E Bovenkamp

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular neurodegeneration, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sharyn L Rossi *BrightFocus Foundation, 22512 Gateway Center Dr, Clarksburg, 20871, MD, USA.
Preeti Subramanian *BrightFocus Foundation, 22512 Gateway Center Dr, Clarksburg, 20871, MD, USA.
Guojun BuDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Adriana Di PoloDepartments of Neuroscience and Ophthalmology, Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), University of Montreal, Montreal, QC, Canada.
Todd E GoldeDepartments of Neuroscience and Neurology, Norman Fixel Institute for Neurological Diseases, Center for Translational Research in Neurodegenerative Disease, Evelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, Fl, USA.
Diane E BovenkampBrightFocus Foundation, 22512 Gateway Center Dr, Clarksburg, 20871, MD, USA. dbovenkamp@brightfocus.org.ORCID 0000-0002-5814-5785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseCerebral Amyloid AngiopathyNeurodegenerative DiseasesParkinson DiseaseBrainHumansAge-related macular degeneration (AMD)AgingAlzheimer’s disease (AD) and related dementiasAstrocytesAxonBiomarkerBlood brain barrier (BBB)Blood retina barrier (BRB)Cellular senescenceCerebral amyloid angiopathy (CAA)ElectrophysiologyEndothelial cellsGeneticGlaucomaHippocampal atrophyImagingInflammationInter-pericyte tunneling nanotubes (IP-TNT)Intraocular pressureIschemicMaintenanceMicrogliaNeurodegenerationNeurovascular unitPericytesRetinal ganglion cells (RGC)Skeletal cellsStrokeThrombosisVascular cognitive impairment and dementia (VCID)Vascular contributionsVasoconstrictionVasodilation

Identifiers

PMID36316783
PMCPMC9623952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.